Abstract:Eight previously undescribed lanostane triterpenoids, ganodeweberiols A ∼ H (1–8), together with eighteen known compounds (9–26), were isolated from the fruiting bodies of Ganoderma weberianum. The structures and absolute configurations of the new compounds were determined by extensive spectroscopic analysis, as well as NMR chemical shifts and electronic circular dichroism (ECD) calculations. Compounds 2, 7, 12, and 14 showed significant α-glucosidase inhibitory activity with IC50 values ranging from 35.3 μM ∼ 223.4 μM compared to the positive control acarbose (IC50, 304.6 μM). Kinetic study indicated that the most potent compound 12 was a mixed type inhibitor for α-glucosidase. Molecular docking simulation revealed the interactions of 12 with α-glucosidase. Additionally, Compounds 3 and 6 inhibited glucagon-induced hepatic glucose production in HepG2 cells with EC50 values of 42.0 and 85.9 μM, respectively. Further study revealed that compounds 3 and 6 inhibited hepatic glucose production by suppression glucagon-induced cAMP accumulation. Moreover, compounds 3 and 26 were active against HeLa cell line with IC50 values of 17.0 and 6.8 μM, respectively.

Two New Lanostanoids from Ganoderma Resinaceum.

Three New Lanostanoids From The Mushroom Ganoderma Tropicum

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

New Lanostane-Type Triterpenoids from Ganoderma Applanatum.

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

Lanostanoids isolated from Ganoderma lucidum mycelium cultured by submerged fermentation

Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.

Two new lanostane triterpenoids from Poria cocos

Structure Elucidation and Complete NMR Spectral Assignments of Three New Lanostanoid Triterpenes with Unprecedented Δ16, 17 Double Bond from Ganoderma Lucidum

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

Highly Oxygenated Lanostane-Type Triterpenoids and Their Bioactivity from the Fruiting Body of Ganoderma Gibbosum

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Lanostane-type Triterpenoids from the Fruiting Body of Ganoderma Calidophilum

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Two New Lanostanoid Triterpenes from the Fruit Body of <i>Ganoderma lucidum</i>-the Major Component of SunRecome<sup>®</sup>

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum